FDA Inspection
K.D. Pharma Bexbach GmbHK.D. Pharma Bexbach GmbH – FDA Inspection, May 14, 2020
Record Details
This FDA Inspection record concerns K.D. Pharma Bexbach GmbH, with an inspection on May 14, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- K.D. Pharma Bexbach GmbH
- Inspection Date
- May 14, 2020
- Product Type
- Drugs
View Company Profile
ID · 8bbb953d-0615-4cfc-a89f-ef3924aea961
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1160099
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of K.D. Pharma Bexbach GmbH
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 16, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2012 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for K.D. Pharma Bexbach GmbH
- FDA Inspection 1289824 - 2023-04-19
- FDA Inspection 1020492 - 2017-06-16
- FDA Inspection 779536 - 2012-03-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.